Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaﾒs proprietary…
-
-
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
-
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
The FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to accelarate Coronavirus disease research
On May 19, 2020, the FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to…
-
New study from pandemic epicenter described severe COVID-19 response in children
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
-
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
-
Thermo Fisher Scientific support of COVID-19 response expanded with US Government contract for products used in sample collection
On May 18, 2020, Thermo Fisher Scientific announced it had received a contract from the U.S. government to…
-
Moderna announced positive interim phase 1 data for mRNA Vaccine against novel Coronavirus
On May 18, 2020, Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus…
-
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
-
Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
-
Hologic granted FDA Emergency Use Authorization for its second molecular test for COVID-19
On May 15, 2020, Hologic announced it had received Emergency Use Authorization (EUA) from the FDA for its…
-
NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
-
Vyriad announced development of new antibody test to determine protective immunity from COVID-19
On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…
-
Countries begin large-scale screening for SARS-CoV-2 in sewage
On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…
-
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
-
AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
-
University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…
-
University of Nebraska developed a COVID-19 screening mobile app
On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…
-
Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…
-
Study confirmed cats can become infected with and may transmit COVID-19 to other cats
On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…
-
LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
On May 12, 2020, LabCorpﾮ announced that its COVID-19 at-home collection test kit is now being offered to…
-
Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mﾙ System
On May 12, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s molecular…
-
Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
-
FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…
-
NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…
-
Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
-
SARS-CoV-2 targets many cell types, analysis of single-cell data suggests
On May 11, 2020, HHMI announced that scientists had identified places the new coronavirus, called SARS-CoV-2, may invade…
-
NanoViricides developed highly effective broad-spectrum drug candidates against Coronaviruses
On May 11, 2020, NanoViricides announced it had developed drug candidates demonstrated very high anti-viral effectiveness in cell…
-
Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
-
Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
